Urinary Incontinence : News
Print
Email
SaveHealthline's Premium Tools
Healthline Part D Plan Selector
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
|
UroToday.com - The role of bladder sensation has recently been highlighted as a way of understanding the sensory pathophysiology of lower urinary tract dysfunction.
|
|
My email for questions is joeedwardsmd@gmail.com . Urinary leakage, also known as urinary incontinence, is extremely common.
|
|
... cancer, acid reflux disease, gallstones, liver disease, lower back pain, renal cell cancer, sleep apnea, and urinary incontinence, are also conditions directly affected by being overweight. They are conditions which take an enormous toll on the ...
|
|
... a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... included in the study. 51 sets of MDCT and conventional cystographic images were evaluated. Results showed that the urinary leak detection rate using MDCT cystography was 80.4%; that compares to the 54.3% detection rate using conventional ...
|
|
... a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... million. Since that time, the company has focused its resources on products that include experimental treatments for urinary incontinence and breast pain. Phase-III testing for both products, typically the final step in seeking new product approval, ...
|
|
... a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... Pelvic or abdominal pain. A change in bladder habits, such as urgent or frequent feelings of needing to go (urinary incontinence). Trouble eating or feeling full quickly. Constipation. Fatigue. Frequent or painful urination. Back pain. Loss of ...
|
|
... a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
 |
 |
Home | About | Health Experts | Careers | Site Map | Feedback | Help | Health Tools | Tell a Friend
Advertise | Terms of Use | Privacy Policy
Advertise | Terms of Use | Privacy Policy
Copyright © 2005 - 2008 Healthline Networks, Inc. All rights reserved.